126 related articles for article (PubMed ID: 10036974)
1. Mutations in the BRCA1 gene: implications of inter-population differences for predicting the risk of radiation-induced breast cancers.
Chakraborty R; Sankaranarayanan K
Genet Res; 1998 Dec; 72(3):191-8. PubMed ID: 10036974
[TBL] [Abstract][Full Text] [Related]
2. Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. IV. Prediction of risks in relatives of cancer-predisposed individuals.
Chakraborty R; Little MP; Sankaranarayanan K
Radiat Res; 1998 May; 149(5):493-507. PubMed ID: 9588361
[TBL] [Abstract][Full Text] [Related]
3. Impact of cancer predisposition and radiosensitivity on the population risk of radiation-induced cancers.
Sankaranarayanan K; Chakraborty R
Radiat Res; 2001 Nov; 156(5 Pt 2):648-56. PubMed ID: 11604087
[TBL] [Abstract][Full Text] [Related]
4. Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. III. Effects of incomplete penetrance and dose-dependent radiosensitivity on cancer risks in populations.
Chakraborty R; Little MP; Sankaranarayanan K
Radiat Res; 1997 Mar; 147(3):309-20. PubMed ID: 9052677
[TBL] [Abstract][Full Text] [Related]
5. Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. II. A Mendelian single-locus model of cancer predisposition and radiosensitivity for predicting cancer risks in populations.
Chakraborty R; Sankaranarayanan K
Radiat Res; 1995 Sep; 143(3):293-301. PubMed ID: 7652167
[TBL] [Abstract][Full Text] [Related]
6. Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. I. Background.
Sankaranarayanan K; Chakraborty R
Radiat Res; 1995 Aug; 143(2):121-43. PubMed ID: 7631005
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: a review.
Bernier J; Poortmans P
Breast; 2015 Apr; 24(2):100-6. PubMed ID: 25557581
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.
Vral A; Willems P; Claes K; Poppe B; Perletti G; Thierens H
Mol Med Rep; 2011; 4(5):901-12. PubMed ID: 21725594
[TBL] [Abstract][Full Text] [Related]
9. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
10. Modeling cancer predisposition, radiosensitivity and the risk of radiation-induced cancers.
Mezei G; Kavet R
Radiat Res; 2002 Nov; 158(5):661-2; author reply 662. PubMed ID: 12385645
[No Abstract] [Full Text] [Related]
11. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
[TBL] [Abstract][Full Text] [Related]
12. Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers: biological aspects and computational modeling.
Sankaranarayanan K
Radiat Res; 2000 Dec; 154(6):724-5;discussion 726-7. PubMed ID: 11187012
[No Abstract] [Full Text] [Related]
13. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
Moslehi R; Chu W; Karlan B; Fishman D; Risch H; Fields A; Smotkin D; Ben-David Y; Rosenblatt J; Russo D; Schwartz P; Tung N; Warner E; Rosen B; Friedman J; Brunet JS; Narod SA
Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756
[TBL] [Abstract][Full Text] [Related]
15. BRCA1/2 germline mutations: a marker for radioresistance or radiosensitivity?
Formenti SC; Preston-Martin S; Haffty BG
J Clin Oncol; 2000 Mar; 18(5):1159-60. PubMed ID: 10694571
[No Abstract] [Full Text] [Related]
16. Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations.
Kadouri L; Sagi M; Goldberg Y; Lerer I; Hamburger T; Peretz T
Breast Cancer Res Treat; 2013 Jul; 140(1):207-11. PubMed ID: 23824362
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.
Yao L; Sun J; Zhang J; He Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Breast Cancer Res Treat; 2016 Apr; 156(3):441-445. PubMed ID: 27033093
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal radiosensitivity of triple negative breast cancer patients.
Francies FZ; Herd O; Cairns A; Nietz S; Murdoch M; Slabbert J; Claes KBM; Vral A; Baeyens A
Int J Radiat Biol; 2019 Nov; 95(11):1507-1516. PubMed ID: 31348739
[No Abstract] [Full Text] [Related]
19. Cellular responses to radiation and risk of breast cancer.
Jongmans W; Hall J
Eur J Cancer; 1999 Apr; 35(4):540-8. PubMed ID: 10492625
[TBL] [Abstract][Full Text] [Related]
20. Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.
Bayraktar S; Jackson M; Gutierrez-Barrera AM; Liu D; Meric-Bernstam F; Brandt A; Woodson A; Litton J; Lu KH; Valero V; Arun BK
Breast J; 2015; 21(3):260-7. PubMed ID: 25789811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
